<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-22305" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Physiology, Glucocorticoids</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Chourpiliadis</surname>
            <given-names>Charilaos</given-names>
          </name>
          <aff>General Hospital of Patras, Pathology Department</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Aeddula</surname>
            <given-names>Narothama R.</given-names>
          </name>
          <aff>Deaconess HS, IN University School Med</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Charilaos Chourpiliadis declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Narothama Aeddula declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>17</day>
          <month>7</month>
          <year>2023</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-22305.s1" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>Glucocorticoids are steroid hormones produced from the cortex of adrenal glands (gluco-corti-coids: glucose-cortex-steroids). Glucocorticoids&#x000a0;have&#x000a0;a pivotal role in the glucose, protein, and fat metabolism of the body. They originate from steroid precursors and are synthesized primarily in the zona fasciculata of the adrenal cortex. Their medical significance arises from their anti-inflammatory, anti-allergic, and immune-suppressive role in the body, and this particular role used for medical treatment purposes. One should remember that glucocorticoids are not the infamous anabolic steroids that are used by athletes for muscle buildup. Instead, these are the catabolic steroids that cause peripheral muscle breakdown. The essential glucocorticoid in the body is cortisol. It is released in a diurnal circadian pattern, with the highest levels released at around 8 AM and its lowest levels between midnight and 4 AM.<xref ref-type="bibr" rid="article-22305.r1">[1]</xref></p>
      </sec>
      <sec id="article-22305.s2" sec-type="Cellular Level&#x0000d;&#x0000a;">
        <title>Cellular Level
</title>
        <p>The release of cortisol is under the feed-back control of the hypothalamic-pituitary-adrenal (HPA) axis. Corticotrophin-releasing hormone (CRH) is released from the hypothalamus and stimulates the adrenocorticotropic hormone (ACTH). ACTH acts by binding to a G protein-coupled receptor (the melanocortin two receptor- MC2R). This binding results in the activation of adenylyl cyclase, cAMP production, and activation of protein kinase A (PKA). PKA modifies the activity of specific transcription factors via phosphorylation.</p>
        <p>ACTH actions include, the activation of HMG CoA reductase (the rate-limiting enzyme in cholesterol synthesis), increased LDL-C esters uptake (that are either stored or converted into cholesterol), activation of hormone-sensitive lipase (HSL) and lastly inhibition of acyl-coenzyme A (CoA): cholesterol acyltransferase (ACAT). The above actions of ACTH increased the available cholesterol pool for steroidogenesis. The first step in the steroidogenesis pathway occurs in mitochondria; StAR (induced by ACTH) moves cholesterol to the inner mitochondrial membrane. Desmolase, a CYP450 enzyme, exerts its action by catalyzing a break in the cholesterol side chain.<xref ref-type="bibr" rid="article-22305.r2">[2]</xref><xref ref-type="bibr" rid="article-22305.r3">[3]</xref>&#x000a0;</p>
        <p>Glucocorticoid production in zona fasciculata involves cholesterol desmolase, 17a-hydroxylase, 21-hydroxylase, 11&#x003b2;-hydroxylase. The end product of this pathway is Cortisone. Cortisone (the inactive form of cortisol) is converted by type 1 hydroxysteroid dehydrogenase in the liver to its active form cortisol. Cortisol is released in the blood bound to cortisol binding protein (CBP), which is a globulin protein.<xref ref-type="bibr" rid="article-22305.r4">[4]</xref> Cortisol has the potential to bind and activate both the glucocorticoid receptors and aldosterone receptors. 11&#x003b2;-hydroxysteroid (type II) dehydrogenase by converting cortisol to its inert form cortisone, prevents the cortisol- activation of mineralocorticoid receptors. However, when cortisol levels are high, and 11&#x003b2;-HSD is saturated, cortisol can activate mineralocorticoid receptors. Usually, this is a result of treatment with exogenous glucocorticoids at supra-physiologic doses.<xref ref-type="bibr" rid="article-22305.r5">[5]</xref>&#x000a0;</p>
        <p>Upon binding to an intracellular cytoplasmic glucocorticoid receptor (GR), the Cortisol-GR complex is translocated inside the nucleus. The compound acts at the DNA level, affecting the expression in a variety of genes and inducing various effects on different cells of the body like fibroblasts, white blood cells, etc.<xref ref-type="bibr" rid="article-22305.r6">[6]</xref></p>
        <p>Cortisol half-life is 66 minutes, under normal conditions. The enzymatic system for cortisol metabolism is primarily in the liver. Corticosteroid metabolites are excreted in the urine&#x02014;the primary&#x000a0;urinary metabolite of cortisol Tetrahydrocortisol. A small amount of free/ unbound serum cortisol is not reabsorbed in the distal tubule of the kidney and is excreted into the urine. This small amount of cortisol is of diagnostic importance.</p>
      </sec>
      <sec id="article-22305.s3" sec-type="Function">
        <title>Function</title>
        <p>The release of glucocorticoids is pulsatile throughout the day, peaking in the morning at around 8 am. Glucocorticoids are necessary for normal bodily functions. However, any form of stress&#x000a0;(physical, psychological) is an acute inducer of cortisol secretion. Due to its role in stress, cortisol also called the stress hormone of the body.<xref ref-type="bibr" rid="article-22305.r7">[7]</xref></p>
        <p>
<bold>Metabolic Functions</bold>
</p>
        <p>Cortisol acts on glucose metabolism to cause hyperglycemia. This effect is not only involved in maintaining normal glucose homeostasis but at times of stress, glucose happens to be the only substrate that provides energy to the critical organs of the body such as the brain and skeletal muscles during times of stress such as an illness or exercise. Hyperglycemia is caused by increasing the synthesis of enzymes involved in glycogenolysis and gluconeogenesis.<xref ref-type="bibr" rid="article-22305.r8">[8]</xref>&#x000a0;</p>
        <p>Cortisol upregulates or activates or induces enzymes involved in gluconeogenesis and glycogenolysis. It antagonizes the actions of insulin and decreases the cellular uptake of glucose to increase the availability of glucose for the brain, red blood cells, and skeletal muscles. Cortisol increases gluconeogenesis by inducing the gene expression of the PEPCK enzyme. This step occurs in the cytosol; fructose-1,6-bisphosphate converts to fructose-6-phosphate. By antagonizing the actions of insulin, it decreases (a) glycogen synthesis and (b) glucose uptake by glut four transporters.&#x000a0; Glucocorticoids, to further increase the gluconeogenetic substrates, establish a catabolic state in muscles, inducing peripheral muscle breakdown and mobilizing amino acids towards the liver to be used in gluconeogenesis&#x000a0;(formation of glucose from amino acids).</p>
        <p>Furthermore, glucocorticoids activate hormone-sensitive lipase (HSL) in the adipose tissue resulting in increased availability of free fatty acids for beta-oxidation. These metabolic actions of glucocorticoids explain many of the effects of exogenous glucocorticoid medication. Glucocorticoids result in decreased muscle mass; skin gets thinner, fragile, and easy to bruise. Glucocorticoids also result in hyperglycemia and lipodystrophy (redistribution of fat in the back of the neck- buffalo hump, face -moon face- and decrease of adipose tissue in extremities). The mechanism of this fat redistribution is unknown.<xref ref-type="bibr" rid="article-22305.r9">[9]</xref></p>
        <p>
<bold>&#x00391;nti-inflammatory and Immune-suppressive Function</bold>
</p>
        <p>Glucocorticoids result in a net&#x000a0;increase in the WBC count. The increased WBC count, is a combination of a decrease in neutrophil migration in tissues, an inhibition of neutrophil apoptosis, and promote WBC maturation in the Bone Marrow, and release in circulation. With regards to eosinophils, glucocorticoids induce apoptosis and sequestration of eosinophils in the periphery. Inhibition of&#x000a0;interleukin-2 (IL-2) signaling (inhibition of T cell proliferation), the impaired release of cells from lymphoid tissues, T lymphocyte apoptosis, inhibition of NF-kB (decrease in cytokine gene expression) and degranulation inhibition of mast cells are effects of glucocorticoids in lymphatic tissue. In the setting of increased glucocorticoid levels in the blood, the macrophages of the reticuloendothelial system fail to recognize and phagocytose antigens (even opsonized antigens). A sequela of these effects is&#x000a0;the regression in size of lymphoid tissue (thymus, spleen and lymph nodes.)<xref ref-type="bibr" rid="article-22305.r10">[10]</xref></p>
        <p>
<bold>Neurologic Effects</bold>
</p>
        <p>Several individuals who present with hypercortisolemia ( by receiving exogenous doses of glucocorticoids or suffer from Cushing syndrome) may present with depression. This effect of hypercortisolemia, a possible result of&#x000a0;glucocorticoid-induced neuronal excitation, may have a role in the pathogenesis of the major depressive disorder. Affected hypercortisolemic patients present with difficulty falling asleep, a decrease in REM sleep latency, and slow-wave sleep. Also, alterations in&#x000a0;electroencephalogram patterns are&#x000a0;frequent&#x000a0;in these individuals.&#x000a0;Conversely, cortisol&#x000a0;insufficiency&#x000a0;is associated with an inability to perform tasks requiring mental concentration.<xref ref-type="bibr" rid="article-22305.r11">[11]</xref></p>
        <p>HPA axis feedback control regulates levels of endogenously produced glucocorticoids and prevents such drastic effects in the bodily functions. Chronic exogenous glucocorticoid administration has such detrimental effects.</p>
      </sec>
      <sec id="article-22305.s4" sec-type="Mechanism">
        <title>Mechanism</title>
        <p>The majority of the effects of glucocorticoids result from the binding of cortisol to intracellular glucocorticoid receptors (GR). This complex translocates in the nucleus to&#x000a0;change gene expression in a variety of ways. Intracellular GR receptors are bound to stabilizing proteins like Hsp-90 in their steroid-free state.</p>
        <p>Once bound to the glucocorticoid, the steroid-GR complex moves towards the DNA and acts on the GRE (glucocorticoid response element)&#x000a0;elements of DNA.&#x000a0; In this way, the complex induces transcription of the&#x000a0;target&#x000a0;DNA sequence (transactivation), or it acts in combination with other transcription factors to act on other parts of DNA to transactivate or to repress gene transcription. This complex may also attach itself to nGRE (negative glucocorticoid response elements) to downregulate or repress gene transcription directly.<xref ref-type="bibr" rid="article-22305.r12">[12]</xref></p>
        <p>There is a hypothesis that glucocorticoids act at a post-translational level. They stabilize or destabilize&#x000a0;specific mRNAs to further modulate protein formation.<xref ref-type="bibr" rid="article-22305.r13">[13]</xref>&#x000a0;</p>
        <p>The anti-inflammatory effects of glucocorticoids are exerted via transpression while the metabolic effects&#x000a0;via &#x0201c;transactivation.&#x0201d;&#x000a0;About 20% of all genes are under the control of glucocorticoids. Transactivation induces the formation of lipocortin-1. Lipocortin 1&#x000a0;decreases the production of&#x000a0;phospholipase A2 (PLA2 is involved in the formation of prostaglandins and leukotrienes), inhibits COX-2 (post-transcriptional activity), promotes neutrophil detachment from the endothelium, and reduces neutrophil&#x000a0;migration&#x000a0;through the endothelium of blood vessels. These events result in an increased WBC count.</p>
        <p>Transpression or gene inhibition decreases (a) the production of COX-2, (b) inducible NOS, and(c) most inflammatory cytokines (IL-1 thru IL-6, IL-8, IL-10, IL-13, GM-CSF, TNF-&#x003b1;, Interferon-&#x003b3;). Other effects of glucocorticoids on protein, fat, and glucose metabolism are also&#x000a0;exerted via the same mechanism of action, i.e., by modulating enzyme synthesis, which in turn controls subsequent events.<xref ref-type="bibr" rid="article-22305.r14">[14]</xref></p>
      </sec>
      <sec id="article-22305.s5" sec-type="Related Testing">
        <title>Related Testing</title>
        <p>Some points that one must recall about cortisol testing:</p>
        <p>(a) Cortisol secretion exhibits a circadian rhythm.</p>
        <p>(b) Cortisol concentrations increase during stress.</p>
        <p>(c) The level of cortisol binding protein becomes increased in hyper-estrogenic states such as pregnancy, hyperthyroidism, diabetes, and in certain hematological disorders; these cause an increase in serum cortisol levels to help maintain equilibrium between the bound and unbound state of cortisol. CBG may decrease in familial CBG deficiency, hypothyroidism, and protein deficiency states such as severe liver disease and nephrotic syndrome.&#x000a0;Cortisol levels are also increased by drugs containing estrogen, synthetic glucocorticoids, such as prednisone, pregnancy, and decreased by drugs such as androgens and phenytoins.<xref ref-type="bibr" rid="article-22305.r15">[15]</xref><xref ref-type="bibr" rid="article-22305.r16">[16]</xref><xref ref-type="bibr" rid="article-22305.r17">[17]</xref><xref ref-type="bibr" rid="article-22305.r18">[18]</xref><xref ref-type="bibr" rid="article-22305.r19">[19]</xref><xref ref-type="bibr" rid="article-22305.r20">[20]</xref>&#x000a0;</p>
        <p>Cortisol levels can be established by measurement of cortisol levels in serum/plasma, saliva, or urine. A 24-hour urine collection is required to measure cortisol levels successfully. Normal values range from 2 to 6 &#x003bc;g/24 hours in women and 3&#x000a0;to 10 &#x003bc;g/24 hours in men. Salivary cortisol is in equilibrium with free cortisol and can be employed in children as an alternative to serum measurement.<xref ref-type="bibr" rid="article-22305.r21">[21]</xref><xref ref-type="bibr" rid="article-22305.r22">[22]</xref></p>
      </sec>
      <sec id="article-22305.s6" sec-type="Clinical Significance">
        <title>Clinical Significance</title>
        <p>Glucocorticoids, both synthetic and natural, are used in various disorders.</p>
        <list list-type="order">
          <list-item>
            <p>Endocrinologists use the treatment of adrenal insufficiency and congenital adrenal hyperplasia.</p>
          </list-item>
          <list-item>
            <p>Pharmacologic doses of the glucocorticoids are used to treat various allergic, immunological, and inflammatory disorders.</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-22305.s7">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=22305&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=22305">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/22305/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=22305">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <ref-list id="article-22305.s8">
        <title>References</title>
        <ref id="article-22305.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Zamanian</surname>
                <given-names>Z</given-names>
              </name>
              <name>
                <surname>Dehghani</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Hashemi</surname>
                <given-names>H</given-names>
              </name>
            </person-group>
            <article-title>Outline of changes in cortisol and melatonin circadian rhythms in the security guards of shiraz university of medical sciences.</article-title>
            <source>Int J Prev Med</source>
            <year>2013</year>
            <month>Jul</month>
            <volume>4</volume>
            <issue>7</issue>
            <fpage>825</fpage>
            <page-range>825-30</page-range>
            <pub-id pub-id-type="pmid">24049602</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22305.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Malkoski</surname>
                <given-names>SP</given-names>
              </name>
              <name>
                <surname>Dorin</surname>
                <given-names>RI</given-names>
              </name>
            </person-group>
            <article-title>Composite glucocorticoid regulation at a functionally defined negative glucocorticoid response element of the human corticotropin-releasing hormone gene.</article-title>
            <source>Mol Endocrinol</source>
            <year>1999</year>
            <month>Oct</month>
            <volume>13</volume>
            <issue>10</issue>
            <fpage>1629</fpage>
            <page-range>1629-44</page-range>
            <pub-id pub-id-type="pmid">10517666</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22305.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Spiga</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Walker</surname>
                <given-names>JJ</given-names>
              </name>
              <name>
                <surname>Terry</surname>
                <given-names>JR</given-names>
              </name>
              <name>
                <surname>Lightman</surname>
                <given-names>SL</given-names>
              </name>
            </person-group>
            <article-title>HPA axis-rhythms.</article-title>
            <source>Compr Physiol</source>
            <year>2014</year>
            <month>Jul</month>
            <volume>4</volume>
            <issue>3</issue>
            <fpage>1273</fpage>
            <page-range>1273-98</page-range>
            <pub-id pub-id-type="pmid">24944037</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22305.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Henley</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Lightman</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Carrell</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>Cortisol and CBG - Getting cortisol to the right place at the right time.</article-title>
            <source>Pharmacol Ther</source>
            <year>2016</year>
            <month>Oct</month>
            <volume>166</volume>
            <fpage>128</fpage>
            <page-range>128-35</page-range>
            <pub-id pub-id-type="pmid">27411675</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22305.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Dammann</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Stapelfeld</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Maser</surname>
                <given-names>E</given-names>
              </name>
            </person-group>
            <article-title>Expression and activity of the cortisol-activating enzyme 11&#x003b2;-hydroxysteroid dehydrogenase type 1 is tissue and species-specific.</article-title>
            <source>Chem Biol Interact</source>
            <year>2019</year>
            <month>Apr</month>
            <day>25</day>
            <volume>303</volume>
            <fpage>57</fpage>
            <page-range>57-61</page-range>
            <pub-id pub-id-type="pmid">30796905</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22305.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Miller</surname>
                <given-names>WL</given-names>
              </name>
              <name>
                <surname>Auchus</surname>
                <given-names>RJ</given-names>
              </name>
            </person-group>
            <article-title>The molecular biology, biochemistry, and physiology of human steroidogenesis and its disorders.</article-title>
            <source>Endocr Rev</source>
            <year>2011</year>
            <month>Feb</month>
            <volume>32</volume>
            <issue>1</issue>
            <fpage>81</fpage>
            <page-range>81-151</page-range>
            <pub-id pub-id-type="pmid">21051590</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22305.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Russell</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Lightman</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>The human stress response.</article-title>
            <source>Nat Rev Endocrinol</source>
            <year>2019</year>
            <month>Sep</month>
            <volume>15</volume>
            <issue>9</issue>
            <fpage>525</fpage>
            <page-range>525-534</page-range>
            <pub-id pub-id-type="pmid">31249398</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22305.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Exton</surname>
                <given-names>JH</given-names>
              </name>
            </person-group>
            <article-title>Regulation of gluconeogenesis by glucocorticoids.</article-title>
            <source>Monogr Endocrinol</source>
            <year>1979</year>
            <volume>12</volume>
            <fpage>535</fpage>
            <page-range>535-46</page-range>
            <pub-id pub-id-type="pmid">386091</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22305.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Nieman</surname>
                <given-names>LK</given-names>
              </name>
            </person-group>
            <article-title>Cushing's syndrome: update on signs, symptoms and biochemical screening.</article-title>
            <source>Eur J Endocrinol</source>
            <year>2015</year>
            <month>Oct</month>
            <volume>173</volume>
            <issue>4</issue>
            <fpage>M33</fpage>
            <page-range>M33-8</page-range>
            <pub-id pub-id-type="pmid">26156970</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22305.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Coutinho</surname>
                <given-names>AE</given-names>
              </name>
              <name>
                <surname>Chapman</surname>
                <given-names>KE</given-names>
              </name>
            </person-group>
            <article-title>The anti-inflammatory and immunosuppressive effects of glucocorticoids, recent developments and mechanistic insights.</article-title>
            <source>Mol Cell Endocrinol</source>
            <year>2011</year>
            <month>Mar</month>
            <day>15</day>
            <volume>335</volume>
            <issue>1</issue>
            <fpage>2</fpage>
            <page-range>2-13</page-range>
            <pub-id pub-id-type="pmid">20398732</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22305.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Daban</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Vieta</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Mackin</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Young</surname>
                <given-names>AH</given-names>
              </name>
            </person-group>
            <article-title>Hypothalamic-pituitary-adrenal axis and bipolar disorder.</article-title>
            <source>Psychiatr Clin North Am</source>
            <year>2005</year>
            <month>Jun</month>
            <volume>28</volume>
            <issue>2</issue>
            <fpage>469</fpage>
            <page-range>469-80</page-range>
            <pub-id pub-id-type="pmid">15826743</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22305.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Saklatvala</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Glucocorticoids: do we know how they work?</article-title>
            <source>Arthritis Res</source>
            <year>2002</year>
            <volume>4</volume>
            <issue>3</issue>
            <fpage>146</fpage>
            <page-range>146-50</page-range>
            <pub-id pub-id-type="pmid">12010562</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22305.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Rhen</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Cidlowski</surname>
                <given-names>JA</given-names>
              </name>
            </person-group>
            <article-title>Antiinflammatory action of glucocorticoids--new mechanisms for old drugs.</article-title>
            <source>N Engl J Med</source>
            <year>2005</year>
            <month>Oct</month>
            <day>20</day>
            <volume>353</volume>
            <issue>16</issue>
            <fpage>1711</fpage>
            <page-range>1711-23</page-range>
            <pub-id pub-id-type="pmid">16236742</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22305.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Newton</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Holden</surname>
                <given-names>NS</given-names>
              </name>
            </person-group>
            <article-title>Separating transrepression and transactivation: a distressing divorce for the glucocorticoid receptor?</article-title>
            <source>Mol Pharmacol</source>
            <year>2007</year>
            <month>Oct</month>
            <volume>72</volume>
            <issue>4</issue>
            <fpage>799</fpage>
            <page-range>799-809</page-range>
            <pub-id pub-id-type="pmid">17622575</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22305.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Torpy</surname>
                <given-names>DJ</given-names>
              </name>
              <name>
                <surname>Bachmann</surname>
                <given-names>AW</given-names>
              </name>
              <name>
                <surname>Grice</surname>
                <given-names>JE</given-names>
              </name>
              <name>
                <surname>Fitzgerald</surname>
                <given-names>SP</given-names>
              </name>
              <name>
                <surname>Phillips</surname>
                <given-names>PJ</given-names>
              </name>
              <name>
                <surname>Whitworth</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Jackson</surname>
                <given-names>RV</given-names>
              </name>
            </person-group>
            <article-title>Familial corticosteroid-binding globulin deficiency due to a novel null mutation: association with fatigue and relative hypotension.</article-title>
            <source>J Clin Endocrinol Metab</source>
            <year>2001</year>
            <month>Aug</month>
            <volume>86</volume>
            <issue>8</issue>
            <fpage>3692</fpage>
            <page-range>3692-700</page-range>
            <pub-id pub-id-type="pmid">11502797</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22305.r16">
          <label>16</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hannibal</surname>
                <given-names>KE</given-names>
              </name>
              <name>
                <surname>Bishop</surname>
                <given-names>MD</given-names>
              </name>
            </person-group>
            <article-title>Chronic stress, cortisol dysfunction, and pain: a psychoneuroendocrine rationale for stress management in pain rehabilitation.</article-title>
            <source>Phys Ther</source>
            <year>2014</year>
            <month>Dec</month>
            <volume>94</volume>
            <issue>12</issue>
            <fpage>1816</fpage>
            <page-range>1816-25</page-range>
            <pub-id pub-id-type="pmid">25035267</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22305.r17">
          <label>17</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Plechner</surname>
                <given-names>AJ</given-names>
              </name>
            </person-group>
            <article-title>Cortisol abnormality as a cause of elevated estrogen and immune destabilization: insights for human medicine from a veterinary perspective.</article-title>
            <source>Med Hypotheses</source>
            <year>2004</year>
            <volume>62</volume>
            <issue>4</issue>
            <fpage>575</fpage>
            <page-range>575-81</page-range>
            <pub-id pub-id-type="pmid">15050110</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22305.r18">
          <label>18</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kara</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Ucakt&#x000fc;rk</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Aydin</surname>
                <given-names>OF</given-names>
              </name>
              <name>
                <surname>Aydin</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Adverse effect of phenytoin on glucocorticoid replacement in a child with adrenal insufficiency.</article-title>
            <source>J Pediatr Endocrinol Metab</source>
            <year>2010</year>
            <month>Sep</month>
            <volume>23</volume>
            <issue>9</issue>
            <fpage>963</fpage>
            <page-range>963-6</page-range>
            <pub-id pub-id-type="pmid">21175098</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22305.r19">
          <label>19</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Gaffey</surname>
                <given-names>AE</given-names>
              </name>
              <name>
                <surname>Wirth</surname>
                <given-names>MM</given-names>
              </name>
              <name>
                <surname>Hoks</surname>
                <given-names>RM</given-names>
              </name>
              <name>
                <surname>Jahn</surname>
                <given-names>AL</given-names>
              </name>
              <name>
                <surname>Abercrombie</surname>
                <given-names>HC</given-names>
              </name>
            </person-group>
            <article-title>Circulating cortisol levels after exogenous cortisol administration are higher in women using hormonal contraceptives: data from two preliminary studies.</article-title>
            <source>Stress</source>
            <year>2014</year>
            <month>Jul</month>
            <volume>17</volume>
            <issue>4</issue>
            <fpage>314</fpage>
            <page-range>314-20</page-range>
            <pub-id pub-id-type="pmid">24773147</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22305.r20">
          <label>20</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Brownlee</surname>
                <given-names>KK</given-names>
              </name>
              <name>
                <surname>Moore</surname>
                <given-names>AW</given-names>
              </name>
              <name>
                <surname>Hackney</surname>
                <given-names>AC</given-names>
              </name>
            </person-group>
            <article-title>Relationship between circulating cortisol and testosterone: influence of physical exercise.</article-title>
            <source>J Sports Sci Med</source>
            <year>2005</year>
            <month>Mar</month>
            <day>01</day>
            <volume>4</volume>
            <issue>1</issue>
            <fpage>76</fpage>
            <page-range>76-83</page-range>
            <pub-id pub-id-type="pmid">24431964</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22305.r21">
          <label>21</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Inder</surname>
                <given-names>WJ</given-names>
              </name>
              <name>
                <surname>Dimeski</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Russell</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Measurement of salivary cortisol in 2012 - laboratory techniques and clinical indications.</article-title>
            <source>Clin Endocrinol (Oxf)</source>
            <year>2012</year>
            <month>Nov</month>
            <volume>77</volume>
            <issue>5</issue>
            <fpage>645</fpage>
            <page-range>645-51</page-range>
            <pub-id pub-id-type="pmid">22812714</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22305.r22">
          <label>22</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Larsson</surname>
                <given-names>CA</given-names>
              </name>
              <name>
                <surname>Gullberg</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>R&#x000e5;stam</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Lindblad</surname>
                <given-names>U</given-names>
              </name>
            </person-group>
            <article-title>Salivary cortisol differs with age and sex and shows inverse associations with WHR in Swedish women: a cross-sectional study.</article-title>
            <source>BMC Endocr Disord</source>
            <year>2009</year>
            <month>Jun</month>
            <day>21</day>
            <volume>9</volume>
            <fpage>16</fpage>
            <pub-id pub-id-type="pmid">19545400</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
